SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Derivative Liability, Current
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Derivative Liability, Current of $504 as of 2024-06-30, per its 10-Q filed 2024-09-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2024-09-04
- 2024-06-30: Derivative Liability, Current $504.00.
- 2024-03-31: Derivative Liability, Current $2.04K.
- 2023-03-31: Derivative Liability, Current $1.39M.
- 2021-12-31: Derivative Liability, Current $94.03K.
| Period end | Derivative Liability, Current |
|---|---|
| 2024-06-30 | $504.00 10-Q · filed 2024-09-04 |
| 2024-03-31 | $2.04K 10-Q/A · filed 2024-09-04 |
| 2023-03-31 | $1.39M 10-Q · filed 2023-05-25 |
| 2021-12-31 | $94.03K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |